{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T19:19:23Z","timestamp":1776539963326,"version":"3.51.2"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T00:00:00Z","timestamp":1596844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T00:00:00Z","timestamp":1596844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s11910-020-01067-x","type":"journal-article","created":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T08:03:30Z","timestamp":1596873810000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Management of Menstrual Migraine"],"prefix":"10.1007","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9245-6341","authenticated-orcid":false,"given":"Tasjeel","family":"Ansari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Marissa","family":"Lagman-Bartolome","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danny","family":"Monsour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Lay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,8]]},"reference":[{"issue":"10100","key":"1067_CR1","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","volume":"390","author":"T Vos","year":"2017","unstructured":"Vos T, Abajobir AA, Abate KH, Abbafati C, Abbas KM, Abd-Allah F, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990\u20132016: a systematic analysis for the global burden of disease study 2016. Lancet. 2017;390(10100):1211\u201359.","journal-title":"Lancet"},{"issue":"3","key":"1067_CR2","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s10194-012-0424-y","volume":"13","author":"S Sacco","year":"2012","unstructured":"Sacco S, Ricci S, Degan D, Carolei A. Migraine in women: the role of hormones and their impact on vascular diseases. J Headache Pain. 2012;13(3):177\u201389.","journal-title":"J Headache Pain"},{"key":"1067_CR3","doi-asserted-by":"crossref","unstructured":"\u2022 Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1\u2013211 This is the international classification of headache disorders which establishes the diagnostic criteria for the different headache disorders including the different types of menstrual migraine using advances in research.","DOI":"10.1177\/0333102417738202"},{"issue":"4","key":"1067_CR4","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/j.1526-4610.2010.01625.x","volume":"50","author":"EA MacGregor","year":"2010","unstructured":"MacGregor EA, Victor TW, Hu X, Xiang Q, Puenpatom RA, Chen W, et al. Characteristics of menstrual vs non-menstrual migraine: a post hoc, within-woman analysis of the usual-care phase of a nonrandomized menstrual migraine clinical trial. Headache. 2010;50(4):528\u201338.","journal-title":"Headache"},{"issue":"4","key":"1067_CR5","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1177\/0333102413507637","volume":"34","author":"KG Vetvik","year":"2014","unstructured":"Vetvik KG, MacGregor EA, Lundqvist C, Russell MB. Prevalence of menstrual migraine: a population-based study. Cephalalgia. 2014;34(4):280\u20138.","journal-title":"Cephalalgia."},{"issue":"06","key":"1067_CR6","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1055\/s-0037-1607393","volume":"37","author":"S Broner","year":"2017","unstructured":"Broner S, Bobker S, Klebanoff L. Migraine in women. Semin Neurol. 2017;37(06):601\u201310.","journal-title":"Semin Neurol"},{"issue":"1","key":"1067_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s10194-018-0853-3","volume":"19","author":"B\u00c9 Petrovski","year":"2018","unstructured":"Petrovski B\u00c9, Vetvik KG, Lundqvist C, Eberhard-Gran M. Characteristics of menstrual versus non-menstrual migraine during pregnancy: a longitudinal population-based study. J Headache Pain. 2018;19(1):27.","journal-title":"J Headache Pain"},{"issue":"4","key":"1067_CR8","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1111\/head.13291","volume":"58","author":"AH Calhoun","year":"2018","unstructured":"\u2022\u2022 Calhoun AH. Understanding menstrual migraine. Headache. 2018;58(4):626\u201330 This article goes in-depth regarding the declines in estrogen levels and its relationship with migraine. It reviews evidence regarding the estrogen drop by reviewing a series of studies to show support of this hypothesis from an experimental, clinical, and pathophysiologic perspective.","journal-title":"Headache"},{"issue":"6","key":"1067_CR9","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s11916-008-0077-3","volume":"12","author":"VT Martin","year":"2008","unstructured":"Martin VT. New theories in the pathogenesis of menstrual migraine. Current Science Inc. 2008;12(6):453\u201362.","journal-title":"Current Science Inc"},{"key":"1067_CR10","doi-asserted-by":"publisher","first-page":"S124","DOI":"10.1111\/j.1526-4610.2008.01310.x","volume":"48","author":"VT Martin","year":"2008","unstructured":"Martin VT, Lipton RB. Epidemiology and biology of menstrual migraine. Headache. 2008;48:S124\u201330.","journal-title":"Headache"},{"issue":"4 Suppl 1","key":"1067_CR11","first-page":"S3","volume":"53","author":"S Silberstein","year":"1999","unstructured":"Silberstein S, Merriam G. Sex hormones and headache 1999 (menstrual migraine). Neurology. 1999;53(4 Suppl 1):S3\u201313.","journal-title":"Neurology."},{"issue":"5","key":"1067_CR12","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1089\/jwh.2007.0440","volume":"17","author":"LK Mannix","year":"2008","unstructured":"Mannix LK. Menstrual-related pain conditions: dysmenorrhea and migraine. J Women's Health. 2008;17(5):879\u201391.","journal-title":"J Women's Health"},{"issue":"1","key":"1067_CR13","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s10194-018-0956-x","volume":"20","author":"AMJM van den Maagdenberg","year":"2019","unstructured":"\u2022 van den Maagdenberg AMJM, Nyholt DR, Anttila V. Headache Pain. 2019;20(1):5 This article highlights an overview of findings regarding genome-wide association studies and their association with migraine. It provides commentary regarding current disease hypotheses and drawbacks regarding identifying genes and pathways.","journal-title":"Headache Pain"},{"issue":"1","key":"1067_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s10194-018-0857-z","volume":"19","author":"CE Pollock","year":"2018","unstructured":"\u2022\u2022 Pollock CE, Sutherland HG, Maher BH, Lea RA, Haupt LM, Frith A, et al. The NRP1 migraine risk variant shows evidence of association with menstrual migraine. J Headache Pain. 2018;19(1):31 This article reviews single-nucleotide polymorphisms and their association with menstrual migraine. It specifically highlights NRP1 and its potential relationship to menstrual migraine pathophysiology.","journal-title":"J Headache Pain"},{"issue":"5","key":"1067_CR15","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1007\/s11916-012-0282-y","volume":"16","author":"EA MacGregor","year":"2012","unstructured":"MacGregor EA. Classification of perimenstrual headache: clinical relevance. Curr Pain Headache Rep. 2012;16(5):452\u201360.","journal-title":"Curr Pain Headache Rep"},{"issue":"2","key":"1067_CR16","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/head.12978","volume":"57","author":"K Maasumi","year":"2017","unstructured":"\u2022 Maasumi K, Tepper SJ, Kriegler JS. Menstrual migraine and treatment options: review. Headache. 2017;57(2):194\u2013208 This article reviews the published studies from 1970 to 2016 providing an overview of treatment options for menstrual migraine. It provides the authors\u2019 perspective and commentary on the different treatment options for menstrual migraine based on a summary of historically important literature and relevant evidence-based studies.","journal-title":"Headache"},{"issue":"1","key":"1067_CR17","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/head.13203","volume":"58","author":"EM Lichten","year":"2018","unstructured":"Lichten EM. Menstrual migraine and treatment options: review. Headache. 2018;58(1):145\u20136.","journal-title":"Headache"},{"issue":"S1","key":"1067_CR18","doi-asserted-by":"publisher","first-page":"P191","DOI":"10.1186\/1129-2377-14-S1-P191","volume":"14","author":"G Allais","year":"2013","unstructured":"Allais G, Tullo V, Omboni S, Benedetto C, Sances G, Zava D, et al. Frovatriptan vs other triptans in the treatment of menstrual migraine: pooled analysis of three double-blind, randomized, cross-over studies. J Headache Pain. 2013;14(S1):P191 1129-2377-14-S1-P191.","journal-title":"J Headache Pain"},{"key":"1067_CR19","doi-asserted-by":"crossref","unstructured":"Dasgupta A, Krasowski MD. Therapeutic drug monitoring data: a concise guide. London, United Kingdom; San Diego, CA: Academic Press; 2020.","DOI":"10.1016\/B978-0-12-815849-4.00001-3"},{"issue":"10","key":"1067_CR20","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1586\/ern.11.123","volume":"11","author":"G Allais","year":"2011","unstructured":"Allais G, Castagnoli Gabellari I, Rolando S, Benedetto C. Evaluation of the use of sumatriptan\u2013naproxen sodium for menstrual migraine and dysmenorrhea. Expert Rev Neurother. 2011;11(10):1383\u20137.","journal-title":"Expert Rev Neurother"},{"issue":"4","key":"1067_CR21","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1111\/j.1526-4610.2010.01628.x","volume":"50","author":"DA Marcus","year":"2010","unstructured":"Marcus DA, Bernstein CD, Sullivan EA, Rudy TE. Perimenstrual eletriptan prevents menstrual migraine: an open-label study. Headache. 2010;50(4):551\u201362.","journal-title":"Headache"},{"issue":"1","key":"1067_CR22","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1212\/WNL.51.1.307","volume":"51","author":"LC Newman","year":"1998","unstructured":"Newman LC, Lipton RB, Lay CL, Solomon S. A pilot study of oral sumatriptan as intermittent prophylaxis of menstruation-related migraine. Neurology. 1998;51(1):307\u20139.","journal-title":"Neurology."},{"issue":"3","key":"1067_CR23","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1046\/j.1526-4610.2001.111006248.x","volume":"41","author":"L Newman","year":"2001","unstructured":"Newman L, Mannix LK, Landy S, Silberstein S, Lipton RB, Putnam DGP, et al. Naratriptan as short-term prophylaxis of menstrually associated migraine: a randomized, double-blind, placebo-controlled study. Headache. 2001;41(3):248\u201356.","journal-title":"Headache"},{"issue":"10","key":"1067_CR24","doi-asserted-by":"publisher","first-page":"877","DOI":"10.2165\/00023210-200822100-00007","volume":"22","author":"MM Tuchman","year":"2008","unstructured":"Tuchman MM, Hee A, Emeribe U, Silberstein S. Oral zolmitriptan in the short-term prevention of menstrual migraine: a randomized, placebo-controlled study. CNS Drugs. 2008;22(10):877\u201386.","journal-title":"CNS Drugs"},{"issue":"11","key":"1067_CR25","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1111\/j.1468-2982.2009.01840.x","volume":"29","author":"J Brandes","year":"2009","unstructured":"Brandes J, Poole A, Kallela M, Schreiber C, MacGregor E, Silberstein S, et al. Short-term frovatriptan for the prevention of difficult-to-treat menstrual migraine attacks. Cephalalgia. 2009;29(11):1133\u201348.","journal-title":"Cephalalgia."},{"issue":"11","key":"1067_CR26","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1111\/j.1526-4610.1990.hed3011705.x","volume":"30","author":"G Sances","year":"1990","unstructured":"Sances G, Martignoni E, Fioroni L, Blandini F, Facchinetti F, Nappi G. Naproxen sodium in menstrual migraine prophylaxis: a double-blind placebo controlled study. Headache. 1990;30(11):705\u20139.","journal-title":"Headache."},{"issue":"4","key":"1067_CR27","first-page":"176","volume":"5","author":"NS Al-Waili","year":"2000","unstructured":"Al-Waili NS. Treatment of menstrual migraine with prostaglandin synthesis inhibitor mefenamic acid: double-blind study with placebo. Eur J Med Res. 2000;5(4):176\u201382.","journal-title":"Eur J Med Res"},{"issue":"1","key":"1067_CR28","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/head.13665","volume":"60","author":"R Burch","year":"2020","unstructured":"Burch R. Epidemiology and treatment of menstrual migraine and migraine during pregnancy and lactation: a narrative review. Headache. 2020;60(1):200\u201316.","journal-title":"Headache"},{"issue":"5","key":"1067_CR29","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/j.1526-4610.1991.hed3105298.x","volume":"31","author":"F Facchinetti","year":"1991","unstructured":"Facchinetti F, Sances G, Borella P, Genazzani AR, Nappi G. Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium. Headache. 1991;31(5):298\u2013301.","journal-title":"Headache."},{"issue":"2","key":"1067_CR30","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/head.13217","volume":"58","author":"A von Luckner","year":"2018","unstructured":"von Luckner A, Riederer F. Magnesium in migraine prophylaxis-is there an evidence-based rationale? A Systematic Review. Headache. 2018;58(2):199\u2013209.","journal-title":"Headache"},{"issue":"1","key":"1067_CR31","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s10194-016-0684-z","volume":"17","author":"L Grazzi","year":"2016","unstructured":"Grazzi L, Egeo G, Calhoun AH, McClure CK, Liebler E, Barbanti P. Non-invasive vagus nerve stimulation (nVNS) as mini-prophylaxis for menstrual\/menstrually related migraine: an open-label study. J Headache Pain. 2016;17(1):91.","journal-title":"J Headache Pain"},{"key":"1067_CR32","doi-asserted-by":"crossref","unstructured":"\u2022 Dima L, B\u0103lan A, Moga MA, Dinu CG, Dimienescu OG, Varga I, et al. Botulinum toxin a valuable prophylactic agent for migraines and a possible future option for the prevention of hormonal variations-triggered migraines. Toxins (Basel). 2019;11(8):465 This article highlighted the fact onabotulinum toxin is used for chronic migraine; however, there are no population-based studies that look at onabotulinum toxin treatment for menstrual migraine.","DOI":"10.3390\/toxins11080465"},{"issue":"5","key":"1067_CR33","doi-asserted-by":"publisher","first-page":"489.e1","DOI":"10.1016\/j.ajog.2016.12.019","volume":"216","author":"SW Champaloux","year":"2017","unstructured":"\u2022 Champaloux SW, Tepper NK, Monsour M, Curtis KM, Whiteman MK, Marchbanks PA, et al. Use of combined hormonal contraceptives among women with migraines and risk of ischemic stroke. Am J Obstet Gynecol. 2017;216(5):489.e1\u20137 This article examined the association of hormonal contraceptive use and migraine with aura showing an association of 6-fold increase risk of ischemic stroke in women of childbearing age.","journal-title":"Am J Obstet Gynecol"},{"key":"1067_CR34","doi-asserted-by":"crossref","unstructured":"\u2022 Lichten EM. Menstrual migraine and treatment options: review hormonal therapy in the prevention of menstrual migraine. 2018;2(1):1049 This article highlights various published studies on stabilizing estradiol levels above and below 50 pg\/ml threshold to prevent menstrual migraine.","DOI":"10.1111\/head.13203"},{"issue":"12","key":"1067_CR35","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1212\/01.wnl.0000249114.52802.55","volume":"67","author":"EA MacGregor","year":"2006","unstructured":"MacGregor EA, Frith A, Ellis J, Aspinall L, Hackshaw A. Prevention of menstrual attacks of migraine: a double-blind placebo-controlled crossover study. Neurology. 2006;67(12):2159\u201363.","journal-title":"Neurology."},{"issue":"8","key":"1067_CR36","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1111\/j.1526-4610.2012.02211.x","volume":"52","author":"A Calhoun","year":"2012","unstructured":"Calhoun A, Ford S, Pruitt A. The impact of extended-cycle vaginal ring contraception on migraine aura: a retrospective case series. Headache. 2012;52(8):1246\u201353.","journal-title":"Headache."},{"key":"1067_CR37","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1129-2377-15-30","volume":"15","author":"KG Vetvik","year":"2014","unstructured":"Vetvik KG, MacGregor EA, Lundqvist C, Russell MB. Contraceptive-induced amenorrhoea leads to reduced migraine frequency in women with menstrual migraine without aura. J Headache Pain. 2014;15:30.","journal-title":"J Headache Pain"},{"issue":"4 Headache","key":"1067_CR38","first-page":"990","volume":"21","author":"EA MacGregor","year":"2015","unstructured":"MacGregor EA. Migraine management during menstruation and menopause. Continuum (Minneap Minn). 2015;21(4 Headache):990\u20131003.","journal-title":"Continuum (Minneap Minn)"},{"issue":"2","key":"1067_CR39","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/S0015-0282(97)81928-0","volume":"67","author":"SC Murray","year":"1997","unstructured":"Murray SC, Muse KN. Effective treatment of severe menstrual migraine headaches with gonadotropin-releasing hormone agonist and \u2018add-back\u2019 therapy. Fertil Steril. 1997;67(2):390\u20133.","journal-title":"Fertil Steril"},{"issue":"17","key":"1067_CR40","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1212\/WNL.0b013e3182535d20","volume":"78","author":"SD Silberstein","year":"2012","unstructured":"Silberstein SD, Holland S, Freitag F, Dodick DW, Argoff C, Ashman E, et al. Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of neurology and the American Headache Society. Neurology. 2012;78(17):1337\u201345.","journal-title":"Neurology."},{"key":"1067_CR41","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ijsu.2015.07.710","volume":"22","author":"M Arumugam","year":"2015","unstructured":"Arumugam M, Parthasarathy V. Increased incidence of migraine in women correlates with obstetrics and gynaecological surgical procedures. Int J Surg. 2015;22:105\u20139.","journal-title":"Int J Surg"},{"key":"1067_CR42","first-page":"773","volume":"7","author":"P Ripa","year":"2015","unstructured":"Ripa P, Ornello R, Degan D, Tiseo C, Stewart J, Pistoia F, et al. Migraine in menopausal women: a systematic review. Int J Women's Health. 2015;7:773\u201382.","journal-title":"Int J Women's Health"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-020-01067-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11910-020-01067-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-020-01067-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,6]],"date-time":"2022-11-06T07:54:31Z","timestamp":1667721271000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11910-020-01067-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,8]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["1067"],"URL":"https:\/\/doi.org\/10.1007\/s11910-020-01067-x","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,8]]},"assertion":[{"value":"8 August 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Tasjeel Ansari, Ana Marissa Lagman-Bartolome, Christine Lay, and Danny Monsour each declare no potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"45"}}